193 related articles for article (PubMed ID: 34247628)
1. Co-producing a multi-stakeholder Core Outcome Set for distal Tibia and Ankle fractures (COSTA): a study protocol.
Pearson NA; Tutton E; Joeris A; Gwilym S; Grant R; Keene DJ; Haywood KL
Trials; 2021 Jul; 22(1):443. PubMed ID: 34247628
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
[TBL] [Abstract][Full Text] [Related]
4. Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol.
Chapman LS; Redmond AC; Flurey CA; Richards P; Smith TO; Arnold JB; Beaton D; Conaghan PG; Golightly YM; Hannan MT; Hofstetter C; Maxwell LJ; Menz HB; Shea B; Tugwell P; Helliwell P; Siddle HJ
Trials; 2023 Jan; 24(1):65. PubMed ID: 36709309
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey.
MacLennan S; Bekema HJ; Williamson PR; Campbell MK; Stewart F; MacLennan SJ; N'Dow JM; Lam TB
Trials; 2015 Mar; 16():76. PubMed ID: 25887437
[TBL] [Abstract][Full Text] [Related]
7. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting.
Lang KM; Harrison KL; Williamson PR; Huntly BJP; Ossenkoppele G; Geissler J; Bereczky T; Hernández-Rivas JM; Chevrou-Séverac H; Goodbody R; Schulze-Rath R; Bullinger L
Trials; 2020 May; 21(1):437. PubMed ID: 32460828
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of outcome reporting in clinical trials of distal tibia and ankle fractures : the need for a core outcome set.
Pearson NA; Tutton E; Joeris A; Gwilym SE; Grant R; Keene DJ; Haywood KL
Bone Jt Open; 2022 Oct; 3(10):832-840. PubMed ID: 36274288
[TBL] [Abstract][Full Text] [Related]
9. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
[TBL] [Abstract][Full Text] [Related]
10. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia.
Duffy JM; van 't Hooft J; Gale C; Brown M; Grobman W; Fitzpatrick R; Karumanchi SA; Lucas N; Magee L; Mol B; Stark M; Thangaratinam S; Wilson M; von Dadelszen P; Williamson P; Khan KS; Ziebland S; McManus RJ;
Pregnancy Hypertens; 2016 Oct; 6(4):274-278. PubMed ID: 27939467
[TBL] [Abstract][Full Text] [Related]
11. Developing a core outcome set for the treatment of pregnant women with pregestational diabetes-a study protocol.
Kgosidialwa O; Bogdanet D; Egan A; O'Shea PM; Biesty L; Devane D; Dunne F;
Trials; 2020 Dec; 21(1):1017. PubMed ID: 33308263
[TBL] [Abstract][Full Text] [Related]
12. Development of a core outcome set for oral health services research involving dependent older adults (DECADE): a study protocol.
Watson S; McMullan J; Brocklehurst P; Tsakos G; Watt RG; Wassall RR; Sherriff A; Ramsay SE; Karki AJ; Tada S; Lappin C; Donaldson M; McKenna G
Trials; 2020 Jul; 21(1):599. PubMed ID: 32611443
[TBL] [Abstract][Full Text] [Related]
13. Medial malleolus: Operative Or Non-operative (MOON) trial protocol - a prospective randomised controlled trial of operative versus non-operative management of associated medial malleolus fractures in unstable fractures of the ankle.
Carter TH; Oliver WM; Graham C; Duckworth AD; White TO
Trials; 2019 Sep; 20(1):565. PubMed ID: 31514744
[TBL] [Abstract][Full Text] [Related]
14. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
[TBL] [Abstract][Full Text] [Related]
15. Primary outcome measures used in interventional trials for ankle fractures: a systematic review.
McKeown R; Rabiu AR; Ellard DR; Kearney RS
BMC Musculoskelet Disord; 2019 Aug; 20(1):388. PubMed ID: 31455297
[TBL] [Abstract][Full Text] [Related]
16. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
[TBL] [Abstract][Full Text] [Related]
17. Acute severe paediatric asthma: study protocol for the development of a core outcome set, a Pediatric Emergency Reserarch Networks (PERN) study.
Craig S; Babl FE; Dalziel SR; Gray C; Powell C; Al Ansari K; Lyttle MD; Roland D; Benito J; Velasco R; Hoeffe J; Moldovan D; Thompson G; Schuh S; Zorc JJ; Kwok M; Mahajan P; Johnson MD; Sapien R; Khanna K; Rino P; Prego J; Yock A; Fernandes RM; Santhanam I; Cheema B; Ong G; Chong SL; Graudins A;
Trials; 2020 Jan; 21(1):72. PubMed ID: 31931862
[TBL] [Abstract][Full Text] [Related]
18. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
[TBL] [Abstract][Full Text] [Related]
19. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis of distal tibia in open dislocation fractures of the ankle.
Blanke F; Loew S; Ferrat P; Valderrabano V; Ochsner PE; Majewski M
Injury; 2014 Oct; 45(10):1659-63. PubMed ID: 25087074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
